Clinical Trial Update: A Trial Investigating the Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart 15 in Subjects With Type 1 Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update evaluating the pharmacodynamic and pharmacokinetic properties of insulin degludec/insulin aspart in adults with type 1 diabetes;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• insulin degludec/insulin aspart (insulin degludec/insulin aspart)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED